Kymab has successfully raised an additional US$50 million to complete a US$90 million Series B financing. Read the full story
Intarcia Therapeutics announced the closing of a $225 million synthetic royalty financing Read the full story
Kymab has successfully raised an additional US$50 million to complete a US$90 million Series B financing. Read the full story
Mirna Therapeutics announced the completion of a $41.8 million Series D financing Read the full story
MyoKardia announced the successful completion of a $46 million Series B financing Read the full story
CRISPR Therapeutics announced the closing of a Series A and Series B financing totaling USD 64 million Read the full story
GW will issue 1,600,000 American Depositary Shares (“ADSs”), representing 19,200,000 ordinary shares of GW, at a price to the public of $112.00 per ADS on the NASDAQ Global Market Read the full story
Jounce Therapeutics announced the successful completion of a $56 million oversubscribed Series B financing Read the full story
Veracyte has entered into a definitive agreement to sell approximately $40 million of its common stock in a private placement Read the full story
Dimension Therapeutics announced the successful completion of a Series B financing totaling $65 million Read the full story
Innocrin Pharmaceuticals announced the completion of a $28 million Series D financing round Read the full story